Phase II trial of sorafenib and capecitabine for hepatocellular carcinoma in cirrhotic patients.
Yehuda Z. Patt
Research Funding - Bayer
M Houman Fekrazad
No relevant relationships to disclose
Kim A Steinberg
No relevant relationships to disclose
Julie E. Bauman
No relevant relationships to disclose
Sang-Joon Lee
No relevant relationships to disclose
Fa-Chyi Lee
No relevant relationships to disclose